Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$110.93 USD

110.93
3,366,985

-0.01 (-0.01%)

Updated Aug 16, 2024 03:59 PM ET

After-Market: $111.00 +0.07 (0.06%) 4:24 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 38% (95 out of 251)

Industry: Medical - Products

Better trading starts here.

Zacks News

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.

NextGen (NXGN) Q1 Earnings Top Estimates, Revenues Surge Y/Y

NextGen's (NXGN) first-quarter fiscal 2024 results reflect strength in its revenue sources.

Is ACADIA Pharmaceuticals (ACAD) Stock Outpacing Its Medical Peers This Year?

Here is how Acadia Pharmaceuticals (ACAD) and Abbott (ABT) have performed compared to their sector so far this year.

Company News for Jul 21, 2023

Companies In The News Are: KMI, UAL, ABT, IBM.

Abbott (ABT) Q2 Earnings & Revenues Beat Estimates, Down Y/Y

Abbott (ABT) delivers better-than-expected earnings and revenues in the second quarter of 2023

Abbott (ABT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Abbott (ABT) Q2 Earnings and Revenues Surpass Estimates

Abbott (ABT) delivered earnings and revenue surprises of 3.85% and 2.84%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Tracey Ryniec headshot

5 Big Cap Earnings Charts to Watch This Week

We are going to get a good look at the global economy.

Shaun Pruitt headshot

2 Medical Stocks to Buy as Earnings Approach

Among the broader healthcare space, Abbott Laboratories (ABT) and Intuitive Surgical (ISRG) are two medical stocks that will highlight this week's earnings lineup.

Here's Why You Should Add BD (BDX) Stock in Your Portfolio

BD's (BDX) slew of product launches raises optimism about the stock.

Why Abbott (ABT) Might Surprise This Earnings Season

Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It

Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Abbott (ABT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Abbott (ABT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Nalak Das headshot

5 Stocks to Buy Ahead of Q2 Earnings Next Week

We have narrowed our search to five companies that are set to declare second-quarter earnings results next week. These are: GPC, ABT, AN, SNA, PPG.

What's in Store for Abbott Laboratories (ABT) in Q2 Earnings?

The recent FDA approvals and growing customer demand for core therapeutic lines is likely to have driven Abbott's (ABT) Q2 performance.

ABT vs. LMAT: Which Stock Should Value Investors Buy Now?

ABT vs. LMAT: Which Stock Is the Better Value Option?

Abbott (ABT) Gains But Lags Market: What You Should Know

Abbott (ABT) closed the most recent trading day at $107.50, moving +0.45% from the previous trading session.

AngioDynamics (ANGO) to Report Q4 Earnings: What's in the Cards?

AngioDynamics' (ANGO) fiscal fourth quarter's top line is likely to have been driven by strong demand for its products.

Abbott (ABT) Gets FDA Approval for AVEIR DR Leadless Pacemaker

Abbott (ABT) receives FDA approval for the AVEIR DR leadless pacemaker system, featuring the proprietary i2i technology.

Will Abbott (ABT) Beat Estimates Again in Its Next Earnings Report?

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $107.22 in the latest trading session, marking a -1.65% move from the prior day.

Abbott (ABT) Teams Up With the ADA to Evaluate CGM Systems

Abbott (ABT) and ADA are going to offer personalized, therapeutic nutrition for diabetes people using CGM systems.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

Abbott (ABT) closed at $107.79 in the latest trading session, marking a -0.66% move from the prior day.

Abbott (ABT) EPD Sales Aid Growth Amid Currency Headwind

Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.